论文部分内容阅读
Background:Entecavir is guanosine analogue with significant activity against HBV.Entecavir maleate is a derivation of entecavir and had been approved by SFDA(State Food and Drug Administration of China) for phase 3 clinical trial before the beginning of the trial.